期刊
CURRENT INFECTIOUS DISEASE REPORTS
卷 14, 期 6, 页码 668-675出版社
SPRINGER
DOI: 10.1007/s11908-012-0296-y
关键词
Solid organ transplantation; Hematopoietic stem cell transplantation; Mucormycosis; Health-care-associated infection; Pneumocystis pneumonia
资金
- patient association Vaincre la mucoviscidose
- MSD, Astellas
- Gilead Sciences
- Pfizer
Invasive fungal infections continue to be a major cause of morbidity and mortality in severely immunocompromised transplant patients. Although Candida spp. and Aspergillus spp. represent the majority of identified pathogens, other fungi have become increasingly prevalent among this patient population. Diagnosis and treatment of invasive fungal infections remain a challenge in transplant medicine despite recent major advances. In this review, we will emphasize emerging topics in invasive fungal infections in transplantations that occurred in 2011-2012. The current literature was reviewed to synthesize new trends in epidemiology, recent outbreaks, clinical findings, and advances in diagnostic and therapeutic resources.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据